Black Group Investment Partners with Zenzic Oasis to Advance Stem Cell Therapy for Personalised Medicine
- Written by Reporters

- Black Group will invest in Dr. Lim's cutting-edge stem cell research and will lead the development of new therapies based on iPSCs for chronic and acute diseases.
- Both companies will work together to bring these innovative stem cell-based products to regional markets, with a focus on personalised treatments.
- Black Group will oversee the scaling, manufacturing, and distribution of stem cell therapies, ensuring accessibility and quality control of the products through a broadly accessible channel.
The issuer is solely responsible for the content of this announcement.
About Black Group Investment Holding
Black Group Investment Holding is an investment firm with a portfolio focusing on real estate, healthcare, wellness and sustainable ventures. The firm's mission is to build sustainable, high-quality assets that contribute to the well-being of communities and enhance investor value. With a strategic focus on high-growth sectors, Black Group seeks to create value through innovative, forward-thinking investments that align with emerging global trends. Leveraging a deep market understanding, strong deal-sourcing capabilities, and biotechnology expertise, the firm identifies and capitalises on opportunities that offer long-term growth. For more information, please visit https://www.blackgroupinvestment.com/
About Zenzic Oasis Holdings Pte Ltd
Founded by Dr. Lim Kah Meng, Zenzic Oasis is a regenerative medicine company with stem cell manufacturing innovations and with a focus on immunological and neurological functional foods to complement and synergise cell regeneration strategies with immunological and neurological optimisation plans. The company has four entities that collectively embody innovation, sustainability, and groundbreaking advancements: NeuroSC, NeuroExo, Cell Fate Engineering and Zenzic Labs. For more information, please visit https://zenzicoasis.com.
Source https://www.media-outreach.com/news/singapore/2024/12/27/352642/